Growth Metrics

ClearPoint Neuro (CLPT) Current Deferred Revenue (2017 - 2026)

ClearPoint Neuro's Current Deferred Revenue history spans 14 years, with the latest figure at $1.7 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 21.31% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 21.31% decrease, with the full-year FY2025 number at $1.7 million, down 21.31% from a year prior.
  • Current Deferred Revenue hit $1.7 million in Q4 2025 for ClearPoint Neuro, down from $1.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CLPT hit a ceiling of $3.2 million in Q4 2023 and a floor of $368000.0 in Q2 2021.
  • Historically, Current Deferred Revenue has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 42.71% in 2021 and later soared 136.78% in 2023.
  • Tracing CLPT's Current Deferred Revenue over 5 years: stood at $678000.0 in 2021, then skyrocketed by 114.9% to $1.5 million in 2022, then soared by 116.47% to $3.2 million in 2023, then tumbled by 32.75% to $2.1 million in 2024, then fell by 21.31% to $1.7 million in 2025.
  • Business Quant data shows Current Deferred Revenue for CLPT at $1.7 million in Q4 2025, $1.7 million in Q3 2025, and $1.4 million in Q2 2025.